Mechanistically, GSK3β inhibition promoted up-regulation of LFA-1 on NK cells and its partner ICAM-1 on AML cells, associated with increased AML–NK cell conjugates (172). The gene discussed is ICAM1; the disease is acute myeloid leukemia.